Gene therapy for HIV infection: what does it need to make it work?
- PMID: 16598816
- DOI: 10.1002/jgm.908
Gene therapy for HIV infection: what does it need to make it work?
Abstract
The efficacy of antiviral drug therapy for HIV infection is limited by toxicity and viral resistance. Thus, alternative therapies need to be explored. Several gene therapeutic strategies for HIV infection have been developed, but in clinical testing therapeutically effective levels of the transgene product were not achieved. This review focuses on the determinants of therapeutic efficacy and discusses the potential and also the limits of current gene therapy approaches for HIV infection.
Copyright 2006 John Wiley & Sons, Ltd.
Similar articles
-
Gene therapy for HIV infection.Clin Exp Immunol. 1997 Jan;107 Suppl 1:41-4. Clin Exp Immunol. 1997. PMID: 9020935
-
Current status of gene therapy strategies to treat HIV/AIDS.Mol Ther. 2005 Jun;11(6):823-42. doi: 10.1016/j.ymthe.2005.01.020. Mol Ther. 2005. PMID: 15922953 Review.
-
Current developments in anti-HIV/AIDS gene therapy.Curr Opin Investig Drugs. 2009 Feb;10(2):137-49. Curr Opin Investig Drugs. 2009. PMID: 19197791 Review.
-
[Gene therapy in HIV infection and other viral infections].Tidsskr Nor Laegeforen. 2001 Feb 10;121(4):473-8. Tidsskr Nor Laegeforen. 2001. PMID: 11255866 Review. Norwegian.
-
Gene therapy for HIV-1 infection: are lethal genes a valuable tool?Cell Mol Biol (Noisy-le-grand). 2005 Sep 2;51(1):93-101. Cell Mol Biol (Noisy-le-grand). 2005. PMID: 16171568 Review.
Cited by
-
The use of cell-delivered gene therapy for the treatment of HIV/AIDS.Immunol Res. 2010 Dec;48(1-3):84-98. doi: 10.1007/s12026-010-8169-7. Immunol Res. 2010. PMID: 20737298 Review.
-
A quantitative comparison of anti-HIV gene therapy delivered to hematopoietic stem cells versus CD4+ T cells.PLoS Comput Biol. 2014 Jun 19;10(6):e1003681. doi: 10.1371/journal.pcbi.1003681. eCollection 2014 Jun. PLoS Comput Biol. 2014. PMID: 24945407 Free PMC article.
-
In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy.Retrovirology. 2010 Oct 9;7:83. doi: 10.1186/1742-4690-7-83. Retrovirology. 2010. PMID: 20932334 Free PMC article.
-
Phase I/II Clinical Trials Using Gene-Modified Adult Hematopoietic Stem Cells for HIV: Lessons Learnt.Stem Cells Int. 2011;2011:393698. doi: 10.4061/2011/393698. Epub 2011 Jun 13. Stem Cells Int. 2011. PMID: 21716651 Free PMC article.
-
Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.Nat Med. 2009 Mar;15(3):285-92. doi: 10.1038/nm.1932. Epub 2009 Feb 15. Nat Med. 2009. PMID: 19219022 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical